HALEH DEJAM: Open Payments
NPI 1275107310 · MISSION VIEJO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$517 in 11 payments from 5 companies in 2025. Trend: 2023 $187 · 2024 $439 · 2025 $517
Food & beverage: $517
| Company | Payments | Amount |
|---|---|---|
| REVANCE THERAPEUTICS, INC. | 4 | $214 |
| ABBVIE INC. | 4 | $99 |
| Lilly USA, LLC | 1 | $98 |
| GlaxoSmithKline, LLC. | 1 | $83 |
| PFIZER INC. | 1 | $23 |
Products named: DAXXIFY, ZEPBOUND, DALVANCE, TEFLARO, ELIQUIS.
Industry payments across CA — which companies pay providers there.
